Page 20 - டோ ஜோன்ஸ் நிலைத்தன்மை குறியீடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy

azacitidine significantly improved overall survival in patients ineligible for intensive chemotherapy, a patient population who typically have a five-year overall survival rate of less than 10% 1 Venclyxto -based combinations to provide clinically meaningful benefits in difficult to treat blood cancers Basel, 25 May 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Venclyxto® (venetoclax) in combination with hypomethylating agents, azacitidine and decitabine, for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy. “This Venclyxto approval is a critical step in providing new therapeutic options for patients in the EU newly diagnosed with AML who cannot tolerate the side effects of, or are ineligible for, intensive chemotherapy,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “Venclyxto-ba

United statesNathalie meetzLevi garrawayVenclexta venclyxtoPatrick barthKarsten kleineNational cancer instituteLeukemia lymphoma societyEuropean commissionDrug administrationCancer treatment centers of americaHead of global product developmentHealth professional versionRoche groupPharmaceuticals industryRoche group media relations

Coca Cola HBC AG (LSE:CCH) | RNS | Coca-Cola HBC AG

22 June 2021, Zug, Switzerland - 21 May 2021 - The Board of Directors of Coca-Cola HBC AG ( Coca-Cola HBC ) has resolved to convene the Annual General Meeting ( AGM ) to be held on Tuesday, 22 June 2021 at Switzerland. As a result of the Coronavirus pandemic, the Swiss Government has issued emergency laws prohibiting physical attendance by shareholders at the AGM. Due to these restrictions, the AGM this year will be a closed meeting and shareholders will not be able to attend in person. Voting will take place exclusively through the independent proxy. The participation of shareholders is very important to Coca-Cola HBC and all shareholders are encouraged to participate in the AGM by appointing the independent proxy, according to the details set out in the notice of AGM.

United statesUnited kingdomCity ofSwitzerland generalAlexandra papalexopoulouHenrique braunAnna diamantopoulouBruno pietracciZoran bogdanovicSchweizerisches handelsamtsblattWilliamw douglasBryan rudolphAlfredo riveraOctavio reyesAnastasiosi leventisCharlottej boyle

Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19

Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19 The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19 Accurate, reliable and early detection of SARS-CoV-2 in potentially exposed individuals can help limit the spread of disease PLEASANTON, Calif., May 18, 2021 /PRNewswire/ Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its cobas SARS-CoV-2 Test for use on the widely available, high-throughput cobas 6800/8800 Systems has received Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for testing individuals without symptoms or reasons to suspect COVID-19. This authorisation supports the guidance update from the U.S. Centers for Disease Control and Prevention (CDC) to expand SARS-CoV

United statesMike weistElizabeth baxterCindy perettieCenters for diseaseUs centers for diseaseHead of molecular labWorld health organizationDrug administrationRoche diagnostics solutionsClinical laboratory improvement amendmentsRoche groupPharmaceuticals industryDrug administration emergency use authorizationUse authorisationEmergency use authorisation

BAT recognised as a Climate Leader by the Financial Times

BAT recognised as a Climate Leader by the Financial Times
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKingsley wheatonExchange commissionBritish american tobaccoGroup new categoriesChief marketing officerFinancial timesBetter tomorrowDow jones sustainability indicesWorld indexNew categoriesBritish american tobaccoSecurities litigation reform actNew categories relatedNew categoryAnnual report

BAT recognised as a Climate Leader by the Financial Times

BAT recognised as a Climate Leader by the Financial Times
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomKingsley wheatonExchange commissionBritish american tobaccoGroup new categoriesClimate leadersBetter tomorrowFinancial timesChief marketing officerDow jones sustainability indicesWorld indexNew categoriesBritish american tobaccoSecurities litigation reform act